Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab. [electronic resource]
- Thrombosis research Aug 2015
- 274-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1879-2472
10.1016/j.thromres.2015.06.008 doi
Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal, Humanized--administration & dosage Anticoagulants--therapeutic use Biomarkers--blood Blood Coagulation--drug effects Female Fibrinolysis--drug effects Hemoglobinuria, Paroxysmal--blood Humans Male Middle Aged Young Adult